Literature DB >> 23652528

Infection prevention in the cancer center.

Kerri A Thom1, Michael Kleinberg, Mary-Claire Roghmann.   

Abstract

Cancer patients are frequently immunosuppressed and at risk for a wide range of opportunistic and healthcare-associated infections. A good infection prevention program is extremely important to reduce risk of infection. This review focuses on infection prevention measures specific to patients, healthcare personnel, and visitors in the cancer center.

Entities:  

Keywords:  cancer center; immune suppressed; infection prevention

Mesh:

Year:  2013        PMID: 23652528      PMCID: PMC3726067          DOI: 10.1093/cid/cit290

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  45 in total

1.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Authors:  Jacques Pépin; Nathalie Saheb; Marie-Andrée Coulombe; Marie-Eve Alary; Marie-Pier Corriveau; Simon Authier; Michel Leblanc; Geneviève Rivard; Mathieu Bettez; Valérie Primeau; Martin Nguyen; Claude-Emilie Jacob; Luc Lanthier
Journal:  Clin Infect Dis       Date:  2005-09-20       Impact factor: 9.079

2.  Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory Committee.

Authors:  E A Bolyard; O C Tablan; W W Williams; M L Pearson; C N Shapiro; S D Deitchmann
Journal:  Infect Control Hosp Epidemiol       Date:  1998-06       Impact factor: 3.254

3.  Guideline for prevention of catheter-associated urinary tract infections 2009.

Authors:  Carolyn V Gould; Craig A Umscheid; Rajender K Agarwal; Gretchen Kuntz; David A Pegues
Journal:  Infect Control Hosp Epidemiol       Date:  2010-04       Impact factor: 3.254

4.  Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee.

Authors:  J S Garner
Journal:  Infect Control Hosp Epidemiol       Date:  1996-01       Impact factor: 3.254

5.  Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia.

Authors:  S L Gerson; G H Talbot; S Hurwitz; B L Strom; E J Lusk; P A Cassileth
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

6.  Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients.

Authors:  R J Sherertz; A Belani; B S Kramer; G J Elfenbein; R S Weiner; M L Sullivan; R G Thomas; G P Samsa
Journal:  Am J Med       Date:  1987-10       Impact factor: 4.965

7.  Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: a prospective cohort study.

Authors:  P Mollee; M Jones; J Stackelroth; R van Kuilenburg; W Joubert; J Faoagali; D Looke; J Harper; A Clements
Journal:  J Hosp Infect       Date:  2011-04-02       Impact factor: 3.926

8.  Invasive pulmonary aspergillosis: identification of risk factors.

Authors:  Mohamed Farouk Allam; Amparo Serrano Del Castillo; Carmen Díaz-Molina; Rafael Fernández-Crehuet Navajas
Journal:  Scand J Infect Dis       Date:  2002

9.  Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

Authors:  D Neofytos; D Horn; E Anaissie; W Steinbach; A Olyaei; J Fishman; M Pfaller; C Chang; K Webster; K Marr
Journal:  Clin Infect Dis       Date:  2009-02-01       Impact factor: 9.079

Review 10.  Community respiratory virus infections in immunocompromised patients with cancer.

Authors:  E Whimbey; J A Englund; R B Couch
Journal:  Am J Med       Date:  1997-03-17       Impact factor: 4.965

View more
  11 in total

Review 1.  Prophylactic Measures During Induction for Acute Myeloid Leukemia.

Authors:  Matthew W McCarthy; Thomas J Walsh
Journal:  Curr Oncol Rep       Date:  2017-03       Impact factor: 5.075

2.  Paranasal sinusitis at the initiation of chemotherapy is a risk factor for invasive fungal disease in children and adolescents with cancer.

Authors:  Kenji Kishimoto; Ryoji Kobayashi; Daiki Hori; Satoru Matsushima; Masato Yanagi; Hirozumi Sano; Daisuke Suzuki; Kunihiko Kobayashi
Journal:  Support Care Cancer       Date:  2021-03-22       Impact factor: 3.603

3.  Developing a tool for nurses to assess risk of infection in pediatric oncology patients in China: a modified Delphi study.

Authors:  Yufeng Zhou; Yan Cui; Hong Wang; Fang Wang; Chao Lu; Yan Shen
Journal:  J Biomed Res       Date:  2016-06-18

4.  Bacterial profile, antibiotic resistance pattern and associated factors among cancer patients at University of Gondar Hospital, Northwest Ethiopia.

Authors:  Alelign Fentie; Yitayih Wondimeneh; Abera Balcha; Anteneh Amsalu; Birhanemeskel Tegene Adankie
Journal:  Infect Drug Resist       Date:  2018-11-08       Impact factor: 4.003

Review 5.  Update on infection control practices in cancer hospitals.

Authors:  Ella J Ariza-Heredia; Roy F Chemaly
Journal:  CA Cancer J Clin       Date:  2018-07-09       Impact factor: 508.702

6.  County-level longitudinal clustering of COVID-19 mortality to incidence ratio in the United States.

Authors:  Nasim Vahabi; Masoud Salehi; Julio D Duarte; Abolfazl Mollalo; George Michailidis
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

7.  Telemedicine trends at a comprehensive cancer center during the first wave of the COVID-19 pandemic.

Authors:  Michael R Moentmann; Jared Johnson; Michael T Chung; Olivia E Yoo; Ho-Sheng Lin; George H Yoo
Journal:  J Surg Oncol       Date:  2021-09-25       Impact factor: 2.885

8.  Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice.

Authors:  Tatiani Uceli Maioli; Brenda de Melo Silva; Michelle Nobre Dias; Nivea Carolina Paiva; Valbert Nascimento Cardoso; Simone Odilia Fernandes; Cláudia Martins Carneiro; Flaviano Dos Santos Martins; Simone de Vasconcelos Generoso
Journal:  J Negat Results Biomed       Date:  2014-04-11

9.  The Impact of COVID-19 on Radiation Oncology Clinics and Patients With Cancer in the United States.

Authors:  Amanda Rivera; Nitin Ohri; Evan Thomas; Robert Miller; Miriam A Knoll
Journal:  Adv Radiat Oncol       Date:  2020-03-27

10. 

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-02       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.